Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Associatie tussen duur van immuuntherapie en overleving bij gevorderd NSCLC
okt 2023 | Immuuntherapie, Longoncologie